|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| 02:00pm | Novo Nordisk to seek approval soon to sell Wegovy pill in China | RE |
| 09:54am | SoftBank Vision Fund CFO is leaving company, memo shows | RE |
| Market Cap | 148B 128B 118B 110B 207B 14,005B 209B 1,390B 543B 6,858B 556B 544B 23,732B | P/E Ratio 2026 * |
12.2x | P/E Ratio 2027 * | 12.9x |
|---|---|---|---|---|---|
| Enterprise Value | 196B 169B 156B 146B 275B 18,567B 277B 1,842B 720B 9,092B 737B 722B 31,463B | EV / Sales 2026 * |
3.18x | EV / Sales 2027 * | 3.21x |
| Free-Float |
59.05% | Yield 2026 * |
6.74% | Yield 2027 * | 6.71% |
Last Transcript: Pfizer Inc
| Manager | Title | Age | Since |
|---|---|---|---|
Albert Bourla
CEO | Chief Executive Officer | 64 | 01/01/2019 |
David Denton
DFI | Director of Finance/CFO | 61 | 02/05/2022 |
| Chief Tech/Sci/R&D Officer | - | 01/01/2007 |
| Director | Title | Age | Since |
|---|---|---|---|
Suzanne Johnson
BRD | Director/Board Member | 68 | 01/09/2007 |
Shantanu Narayen
BRD | Director/Board Member | 62 | 27/09/2013 |
Albert Bourla
CHM | Chairman | 64 | 01/01/2020 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.32% | -1.72% | +37.83% | +148.79% | 1,007B | |
| -2.16% | +1.51% | +50.01% | +43.93% | 567B | |
| -2.70% | -0.66% | +15.97% | +63.07% | 392B | |
| -0.08% | +1.05% | +20.91% | +18.37% | 328B | |
| -0.17% | +1.23% | +24.35% | +32.04% | 277B | |
| +0.64% | -2.56% | +22.78% | +12.68% | 275B | |
| -0.04% | +6.05% | -42.62% | -48.22% | 196B | |
| -1.31% | +1.39% | +18.74% | +53.45% | 189B | |
| -1.03% | -2.97% | +13.02% | +57.34% | 154B | |
| Average | -0.70% | +0.33% | +17.89% | +42.38% | 376.23B | |
| Weighted average by Cap. | -0.59% | -0.03% | +26.52% | +67.14% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 61.69B 53.17B 48.94B 45.91B 86.23B 5,830B 87.09B 579B 226B 2,855B 232B 227B 9,880B | 59.32B 51.13B 47.06B 44.15B 82.92B 5,607B 83.75B 556B 217B 2,746B 223B 218B 9,501B |
| Net income | 11.07B 9.54B 8.78B 8.24B 15.47B 1,046B 15.63B 104B 40.55B 512B 41.54B 40.66B 1,773B | 10.96B 9.45B 8.69B 8.16B 15.32B 1,036B 15.47B 103B 40.15B 507B 41.13B 40.26B 1,755B |
| Net Debt | 48.28B 41.61B 38.29B 35.93B 67.48B 4,563B 68.16B 453B 177B 2,234B 181B 177B 7,731B | 42.08B 36.27B 33.38B 31.31B 58.82B 3,977B 59.4B 395B 154B 1,947B 158B 155B 6,738B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Select your edition
All financial news and data tailored to specific country editions
